Cannabis Bioscience International Holdings, Inc. Share Price

Equities

CBIH

US16948K1060

Biotechnology & Medical Research

Market Closed - OTC Markets 20:53:55 25/06/2024 BST 5-day change 1st Jan Change
0.0009 USD -14.29% Intraday chart for Cannabis Bioscience International Holdings, Inc. -30.77% +12.50%
Sales 2022 215K 16.95M Sales 2023 317K 24.97M Capitalization 5.02M 396M
Net income 2022 - 0 Net income 2023 -1M -78.83M EV / Sales 2022 63.8 x
Net Debt 2022 355K 27.98M Net Debt 2023 381K 30.03M EV / Sales 2023 17 x
P/E ratio 2022
-14.2 x
P/E ratio 2023
-4.39 x
Employees 2
Yield 2022 *
-
Yield 2023
-
Free-Float 60.1%
More Fundamentals * Assessed data
Dynamic Chart
1 day-14.29%
1 week-30.77%
Current month+50.00%
1 month+50.00%
6 months-10.00%
Current year+12.50%
More quotes
1 week
0.00
Extreme 0.0008
0.00
1 month
0.00
Extreme 0.0005
0.00
Current year
0.00
Extreme 0.0004
0.00
1 year
0.00
Extreme 0.0003
0.00
3 years
0.00
Extreme 0.0003
0.01
5 years
0.00
Extreme 0
0.01
10 years
0.00
Extreme 0
0.27
More quotes
Managers TitleAgeSince
Chief Executive Officer 68 18/12/19
Director/Board Member 65 18/12/19
Human Resources Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 68 18/12/19
Director/Board Member 65 18/12/19
More insiders
Date Price Change Volume
25/06/24 0.0009 -14.29% 11,340,202
24/06/24 0.00105 -4.55% 22,785,896
21/06/24 0.0011 0.00% 9,175,064
20/06/24 0.0011 -15.38% 25,722,218
18/06/24 0.0013 -24.64% 92,830,153

Delayed Quote OTC Markets, June 25, 2024 at 08:53 pm

More quotes
Cannabis Bioscience International Holdings, Inc. provides educational and other services to the cannabis industry. The Company provides educational systems focused on medical cannabis in cities throughout the United States and six countries in Latin America. The Company’s segments include Pharmacology University Business and Alpha Research Business. Through the Pharmacology University Business, the Company provides knowledge and promotes professionalism in the rapidly growing worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. Through the Alpha Research Business, based in Houston, Texas, the Company offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. These trials have included drugs relating to diseases in the areas of asthma, allergies, renal disorders, neurology disorders, cardiac and vascular disorders and others.
More about the company